To determine which signaling pathways might be involved in the 2HF action on melanoma cells, we tested its effects on signaling pathways known to be regulated by CDE, shown previously to be altered by Rlip-deficiency, or reported to cause treatment resistance in melanoma. The gene discussed is RALBP1; the disease is melanoma.